Skip to main content
713.442.0427
MyKelseyOnline
Latest COVID-19 information. Read more
713.442.0427 713.442.5818
Text Size:
En Español

Specialty

Ophthalmology

Language(s) Spoken

English; Mandarin

Joined Kelsey-Seybold

August 2018

Accepting New Patients?

Yes

​​​​Professional Backgro​und

Dr. Jeanie Ling completed her medical degree in 2013 from Baylor College of Medicine in Houston. She completed her residency in Ophthalmology in 2017 at Vanderbilt University Medical Center in Nashville. She also completed her Fellowship in glaucoma at The University of Texas Houston Health Science Center in 2018. After graduation, Dr. Ling joined Kelsey-Seybold’s Ophthalmology Department in August 2018 and cares for patients at the Berthelsen Main Campus and Tanglewood Clinic. 

Professional Associati​​ons

Dr. Ling is a member of the Texas Medical Association, the American Academy of Ophthalmology, American Glaucoma Society, and the Association for Research in Vision and Ophthalmology. 

Hob​bies and Interests

Dr. Ling enjoys photography, opera, dance, and travel.

Fun Facts

Dr. Ling’s one guilty pleasure is reading detective novels. The most exotic or interesting places she’s visited are Morocco, Nepal, and India.​

​I strive for the best possible patient outcomes and to provide a full range of services in patient care and education. I believe in engaging patients and families as partners in healing.

​​

​​​​​​​​​​​​By Phone

Our Contact Center is here to serve you, 24 hours a day, 7 days a week.



713-442-0427​​​​
​​

Awards & Recognitions

  • ​Dr. Ling has received multiple awards, the most recent of which was a New World Medical Humanitarian Fellowship in 2017.

Pu​blications

  • Ling JD, Hashemi N, Lee AG. Giant cell arteritis first presenting as throat pain. Journal of Neuro-ophthalmology. 2012 Dec; 32(4): 384.

  • Ling JD, Chao D, Al Zubidi N, Lee AG. Big red flags in neuro-ophthalmology. Can J Ophthalmol. 2013 Feb; 48(1):3-7.

  • Ling JD, Gire A, Pflugfelder S. PROSE Therapy Used to Minimize Corneal Trauma in Patients with Corneal Epithelial Defects. Am J Ophthalmol. 2013 Apr; 155(4):615-619.

  • Al Zubidi N, Ling JD, Lee AG. Atonic pupils secondary to presumed systemic vasopressor-related ischemia. Can J Ophthalmol. 2013 Oct; 48(5):e123-4.

  • Nafiseh H, Ling JD, Soparker C, Sami M, Ellezam B, Klucznik R, Lee AG, Chévez-Barrios P. Onyx transarterial embolization of an orbital solitary fibrous tumor. Ocul Oncol Pathol 2015;1:98–102.

  • Patel S, Ling JD, Kim SJ, Schey KL, Rose K, Kuchtey RW. Proteomic Analysis of Macular Fluid Associated With Advanced Glaucomatous Excavation. JAMA Ophthalmol. 2016 Jan 1;134(1):108-10.

  • Ling JD, Joos KM. A Successful Early Postoperative Shunt Plate Erosion Repair-Case Report. Advances in Ophthalmology & Visual Systems. 2015; 3(2): 82.

  • Ling JD, Mehta V, Fathy C, Rapoport Y, Zhang M, Daniels A, Kohanim S. Racial Disparities in Corneal Transplantation Rates, Complications, and Outcomes. Seminars in Ophthalmology. 2016 Apr 19:0.

  • Mehta V, Ling JD, Mawn L. Socioeconomic Disparities in the Presentation of Acute Bacterial Sinusitis Complications in the Pediatric Population. 2016 Apr 29:1-4.

  • Gregory AC 2nd, Zhang MM, Rapoport Y, Ling JD, Kuchtey RW. Racial Influences of Uveitic Glaucoma: Consolidation of Current Knowledge of Diagnosis and Treatment. Semin Ophthalmol. 2016 Apr 21:0.

  • Rapoport Y, Singer JM, Ling JD, Gregory A, Kohanim S. A Comprehensive Review of Sex Disparities in Symptoms, Pathophysiology, and Epidemiology of Dry Eye Syndrome. Semin Ophthalmol. 2016 Apr 21:0.

  • Zhang M, Tanaka S, Mercier M, Hollar M, Ling JD, Gregory A, Barahimi B. Gender and Racial Disparities in Cases of Autoenucleation. Semin Ophthalmol. 2016 May 4:0.

  • Ling J, Mehta V, Reddy A, Hollar M, Donahue S. An abnormal ocular motor manifestation of Joubert syndrome. J AAPOS. 2017 Feb;21(1):75-77.

  • Ling J, Tauscher R, Mehta V, Zhang M, Daniels A, Kohanim S. The Role for Sentinel Lymph Node Biopsy in the Management of Conjunctival Melanoma. Int Ophthalmol Clin. 2017 Winter;57(1):87-101.

  • Mehta VJ, Ling J, Sobel RK. Review of Targeted Therapies for Periocular Tumors. Int Ophthalmol Clin. 2017 Winter;57(1):153-168. 

Prese​​ntations and abstracts

  • Ling JD, Arlinghaus RB, Ling X. Vaccination with Leukemia Cell Expression Membrane Bound GM-CSF Overcomes the Host Immunosuppression Induced by Leukemia. Blood (ASH Annual Meeting Abstracts) 2008 112: Abstract 5435.

  • Ling JD, Fathy C, Kohanim S. Pediatric Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis: epidemiology and risk factors for ocular involvement. ARVO 2016. 1537 - A0362.

  • Ling JD, Shah AA, Nathan NR,  Chen Q, Seibold LK, Kammer JA. Comparison of femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification cataract surgery (CPCS) in glaucoma, ocular hypertension, and glaucoma suspect patients.  AAO 2016. 

Re​search

  • Cancer Research, 2007-2008
    • To study the effect of vaccination against leukemia with leukemia cell expressing membrane bound GM-CSF in mice
    • Mentor: Ralph Arlinghaus, Ph.D.,
    • MD Anderson Cancer Center, Houston
  • Ophthalmology Research, 2012
    • To study the effect of PROSE therapy in treating recurrent corneal erosion refractory to soft contact lens
    • Mentor: Stephen Pflugfelder, M.D.
    • Baylor College of Medicine, Houston
  • Ophthalmology Research, 2015-2018
    • To compare the presence of caveolin-1 in the retinas of normotensive and ocular hypertensive aged DBA/2J mice.
    • Mentor: Karen Joos, M.D., Ph.D.
    • Vanderbilt Eye Institute, Nashville, Tenn.
  • Ophthalmology Research, 2015-2018
    • Risk factors and demographics of ocular involvement in pediatric erythema multiforme (EM), Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN).
    • Mentor: Sahar Kohanim, M.D., M.P.H
    • Vanderbilt Eye Institute, Nashville, Tenn.
  • Ophthalmology Research, 2016-2018
    • Outcomes of femtosecond laser-assisted cataract surgery in glaucoma, glaucoma suspect, and ocular hypertension patients
    • Mentor: Jeffrey Kammer, M.D.
    • Vanderbilt Eye Institute, Nashville, Tenn.​